1. O’Donnell DE, Milne KM, James MD, de Torres JP, Neder JA.
Dyspnea in COPD: new mechanistic insights and management
implications. Adv Ther. 2020;37(1):41–60. doi:10.1007/s12325-01901128-9
2. O’Donnell DE, Neder JA. The enigma of dyspnoea in COPD:
a physiological perspective. Respirology. 2020;25(2):134–136.
doi:10.1111/resp.13736
3. Ries AL, Bauldoff GS, Carlin BW, et al. Pulmonary rehabilitation:
joint ACCP/AACVPR evidence-based clinical practice guidelines.
Chest. 2007;131(5):4S–42S. doi:10.1378/chest.06-2418
4. Vitacca M, Paneroni M. Rehabilitation of patients with coexisting
COPD and heart failure. J Chronic Obstr Pulm Dis. 2018;15
(3):231–237. doi:10.1080/15412555.2018.1468427
5. Yohannes AM, Baldwin RC, Connolly M. Mortality predictors in
disabling chronic obstructive pulmonary disease in old age. Age
Ageing. 2002;31(2):137–140. doi:10.1093/ageing/31.2.137
6. Raghu G, Collard HR, Egan JJ, et al. An official ATS/ERS/JRS/ALAT
statement: idiopathic pulmonary fibrosis: evidence-based guidelines
for diagnosis and management. Am J Respir Crit Care Med.
2011;183(6):788–824. doi:10.1164/rccm.2009-040GL
7. Matsuda T, Taniguchi H, Ando M, et al. COPD assessment test for
measurement of health status in patients with idiopathic pulmonary
fibrosis: a cross-sectional study. Respirology. 2017;22(4):721–727.
doi:10.1111/resp.12936
8. Nishiyama O, Taniguchi H, Kondoh Y, et al. A simple assessment of
dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis.
Eur
Respir
J.
2010;36(5):1067–1072.
doi:10.1183/
09031936.00152609
9. Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global
strategy for the diagnosis, management, and prevention of chronic
obstructive pulmonary disease (2020 Report); 2020. Available from:
https://goldcopd.org/wp-content/uploads/2019/12/GOLD-2020-FINALver1.2-03Dec19_WMV.pdf. Accessed October 5, 2020.
1870
Powered by TCPDF (www.tcpdf.org)
https://doi.org/10.2147/COPD.S313583
DovePress
Dovepress
10. Vaes AW, Delbressine JML, Mesquita R, et al. Impact of pulmonary
rehabilitation on activities of daily living in patients with chronic
obstructive pulmonary disease. J Appl Physiol. 2018;126(3):607–615.
doi:10.1152/japplphysiol.00790.2018
11. Kozu R, Senjyu H, Jenkins SC, Mukae H, Sakamoto N, Kohno S.
Differences in response to pulmonary rehabilitation in idiopathic
pulmonary fibrosis and chronic obstructive pulmonary disease.
Respiration. 2011;81(3):196–205. doi:10.1159/000315475
12. Yohannes AM, Roomi J, Waters K, Connolly MJ. A comparison of the
Barthel index and Nottingham extended activities of daily living scale
in the assessment of disability in chronic airflow limitation in old age.
Age Ageing. 1998;27(3):369–374. doi:10.1093/ageing/27.3.369
13. Shah S, Vanclay F, Cooper B. Improving the sensitivity of the Barthel
Index for stroke rehabilitation. J Clin Epidemiol. 1989;42
(8):703–709. doi:10.1016/0895-4356(89)90065-6
14. Garrod R, Bestall JC, Paul EA, Wedzicha JA, Jones PW.
Development and validation of a standardized measure of activity
of daily living in patients with severe COPD: the London chest
activity of daily living scale (LCADL). Respir Med. 2000;94
(6):589–596. doi:10.1053/rmed.2000.0786
15. Lareau SC, Meek PM, Roos PJ, Calif LL, Ariz T. Development and
testing of the modified version of the Pulmonary Functional Status
and Dyspnea Questionnaire (PFSDQ-M). Heart Lung. 1998;27
(3):159–168. doi:10.1016/S0147-9563(98)90003-6
16. Vitacca M, Paneroni M, Baiardi P, et al. Development of a Barthel
Index based on dyspnea for patients with respiratory diseases.
Int J Chron Obstruct Pulmon Dis. 2016;11(1):1199–1206.
doi:10.2147/COPD.S104376
17. Janaudis-Ferreira T, Beauchamp MK, Robles PG, Goldstein RS, Brooks D.
Measurement of activities of daily living in patients with COPD: a systematic
review. Chest. 2014;145(2):253–271. doi:10.1378/chest.13-0016
18. Wild D, Grove A, Martin M, et al. Principles of good practice for the
translation and cultural adaptation process for patient-reported out
comes (PRO) measures: report of the ISPOR task force for translation
and cultural adaptation. Value Health. 2005;8(2):94–104.
doi:10.1111/j.1524-4733.2005.04054.x
19. de Vet HCW, Terwee CB, Mokkink LB, Knol DL. Measurement in
Medicine: A Practical Guide. Cambridge, England: Cambridge
University Press; 2011.
20. Miller MR, Hankinson J, Brusasco V, et al. Standardisation of
spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/
09031936.05.00034805
21. ATS Committee on Proficiency Standards for Clinical Pulmonary
Function Laboratories. ATS statement: guidelines for the six-minute
walk test. Am J Respir Crit Care Med. 2002;166(1):111–117.
doi:10.1164/ajrccm.166.1.at1102
22. COSMIN methodology for systematic reviews of Patient-Reported
Outcome Measures (PROMs) user manual. Version 1.0 February
2018. Available from: https://www.cosmin.nl/wp-content/uploads/
COSMIN-syst-review-for-PROMs-manual_version-1_feb-2018-1.
pdf. Accessed October 5, 2020. Accessed May 5, 2021.
23. Guyatt GH, King DR, Feeny DH, et al. Generic and specific mea
surement of health-related quality of life in a clinical trial of respira
tory rehabilitation. J Clin Epidemiol. 1999;52(3):187–192.
doi:10.1016/S0895-4356(98)00157-7
24. Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were
proposed for measurement properties of health status
questionnaires. J Clin Epidemiol. 2007;60(1):34–42. doi:10.1016/j.
jclinepi.2006.03.012
25. de Vet HC, Terwee CB, Knol DL, et al. When to use agreement
versus reliability measures. J Clin Epidemiol. 2006;59
(10):1033–1039. doi:10.1016/j.jclinepi.2005.10.015
26. Kojima S, Ando M, Okazawa H, Sakakibara S, Hashimoto S,
Nakajima S. [Development of a Japanese version of the modified
questionnaire on the pulmonary functional status and dyspnea].
Nihon Kokyuki Gakkai Zasshi. 2004;42(6):486–490. [Japanese]
International Journal of Chronic Obstructive Pulmonary Disease 2021:16
Dovepress
27. Cicchetti DV. Guidelines, criteria, and rules of thumb for evaluating
normed and standardized assessment instruments in psychology.
Psychol Assess. 1994;6(4):284–290. doi:10.1037/1040-3590.6.4.284
Yamaguchi et al
28. Bland JM, Altman DG. Statistics notes: cronbach’s alpha. BMJ.
1997;314(7080):572. doi:10.1136/bmj.314.7080.572
International Journal of Chronic Obstructive Pulmonary Disease
Dovepress
Publish your work in this journal
The International Journal of COPD is an international, peer-reviewed
journal of therapeutics and pharmacology focusing on concise rapid
reporting of clinical studies and reviews in COPD. Special focus is
given to the pathophysiological processes underlying the disease, inter
vention programs, patient focused education, and self management
protocols. This journal is indexed on PubMed Central, MedLine
and CAS. The manuscript management system is completely online
and includes a very quick and fair peer-review system, which is
all easy to use. Visit http://www.dovepress.com/testimonials.php to
read real quotes from published authors.
Submit your manuscript here: https://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journal
International Journal of Chronic Obstructive Pulmonary Disease 2021:16
Powered by TCPDF (www.tcpdf.org)
DovePress
1871
...